All In Biotech

Free tool

FAERS Monitor: Gablofen

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022462 or its brand name (Gablofen, Baclofen). Reports on generic versions are filed under their own applications.

Reports

3,114

Serious

1,575

51% of reports

Hospitalization

807

Death reported

121

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • muscle spasticity771
  • withdrawal syndrome421
  • device issue376
  • drug ineffective294
  • drug withdrawal syndrome272
  • overdose172
  • implant site infection166
  • infection164
  • hypertonia158
  • pruritus157
  • device failure154
  • device malfunction151
  • muscle spasms148
  • implant site extravasation125
  • pain124

Reports by year received

View as table
YearReports
20113
201215
2013333
2014243
2015318
2016145
2017139
2018684
201942
2020247
2021203
2022269
2023170
2024120
2025121
202662

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,045 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
implant site extravasationSignal1251278.41059.4133,108
implant site infectionSignal166519.0445.079,238
muscle spasticitySignal771452.0424.0324,951
hypertoniaSignal158191.6164.228,958
device failureSignal15469.059.110,157
withdrawal syndromeSignal42168.462.527,666
device issueSignal37628.425.99,925
drug withdrawal syndromeSignal27221.018.75,166
device malfunctionSignal15114.512.41,893
infectionSignal1647.76.6949
muscle spasmsSignal1485.54.7538
overdoseSignal1725.44.7616
pruritusSignal1572.82.4178
drug ineffective2941.51.453
pain1241.41.112

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.